Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation

Area of Science:

• Pulmonology
• Transplant Medicine
• Infectious Diseases

Background:

• Solid-organ and hematopoietic stem cell transplant recipients are susceptible to diverse pulmonary complications.
• Pulmonary issues post-transplantation can significantly impact patient outcomes.
• Accurate diagnosis is crucial for effective management of these complications.

Purpose of the Study:

• To provide a comprehensive overview of diagnostic bronchoscopy in transplant recipients.
• To outline recommendations for patient selection, timing, and sample acquisition.
• To discuss the utility and potential adverse effects of bronchoscopy in this population.

Main Methods:

• Literature review on diagnostic bronchoscopy in transplant recipients.
• Analysis of suspected pulmonary complications across acute, subacute, and chronic presentations.
• Evaluation of risks versus benefits of early diagnostic bronchoscopy versus empiric treatment.

Main Results:

• Fiberoptic bronchoscopy is a valuable diagnostic tool for pulmonary complications in transplant patients.
• Early bronchoscopy is recommended over empiric treatment for specific pulmonary processes.
• Identifying infectious etiologies early is critical for optimal patient management.

Conclusions:

• Diagnostic bronchoscopy should be considered early in transplant recipients with pulmonary complications, especially when infection is suspected.
• This approach can mitigate risks associated with empiric therapy, including side effects and antimicrobial resistance.
• Timely and targeted management based on bronchoscopic findings improves patient outcomes.